All In MedTech

Device Trial Radar · NCT04703738

Evaluation of Geistlich Fibro-Gide® in Comparison to CTG for the Treatment Around Implants

A Prospective, Randomized and Controlled Multi-center Study of Geistlich Fibro-Gide® Compared With Connective Tissue Graft for Soft Tissue Volume Augmentation Around Dental Implants

Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Aug 13, 2018

Primary completion

Jun 21, 2021

Study completion May 12, 2026

Sponsor

Lead sponsor
Geistlich Pharma AGNot on our public-company list
Sponsor type
Industry
Collaborators
Medelis Inc.
First posted
Jan 11, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This double blind, randomized, parallel study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for soft tissue volume augmentation around dental implants

Conditions

  • Soft Tissue Defect

Interventions

  • Soft tissue flap + Connective Tissue GraftProcedure

    The treatment site is accessed using a full thickness flap extending at least 1 full tooth mesial and distal, vertical releasing incisions may be used to obtain flap release for full coverage of the treatment site and graft without compression. The harvest graft donor area will be the palate in the bicuspid region on the same side as the control soft tissue augmentation therapy. The CTG will be harvested using full thickness incisions that include the periosteum and will be closed using suture and coating the incision line with a tissue adhesive. No covering stents or packs should be employed. The CTG will be sling sutured in place and the flap secured using a double sling suturing technique.

  • Soft tissue flap + Geistlich Fibro-Gide®Device

    The treatment site is accessed using a full thickness flap extending at least 1 full tooth mesial and distal, vertical releasing incisions may be used to obtain flap release for full coverage of the treatment site and matrix without compression. Geistlich Fibro-Gide® is cut to shape to the treatment site and placed dry into the site. The flap is secured using a double sling suturing technique.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in gingival soft tissue volume assessed with 3D scanningTime frame: 6 months post treatment

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Regenerative Solutions

    Fullerton, California

  • McClain Schallhorn Periodonitcs

    Aurora, Colorado

  • Perio Health Professionals

    Houston, Texas

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.